# Cangrelor Neonatal PK/PD and Safety Study

> **NCT02765633** · PHASE1 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 22 (actual)

## Conditions studied

- Partial Obstruction of Systemic to Pulmonary Artery Shunt
- Complete Obstruction of Systemic to Pulmonary Artery Shunt

## Interventions

- **DRUG:** Cangrelor

## Key facts

- **NCT ID:** NCT02765633
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-03
- **Primary completion:** 2019-08-31
- **Final completion:** 2019-12-23
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02765633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02765633, "Cangrelor Neonatal PK/PD and Safety Study". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02765633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*